Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

780 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Inactive matrix Gla protein is causally related to adverse health outcomes: a Mendelian randomization study in a Flemish population.
Liu YP, Gu YM, Thijs L, Knapen MH, Salvi E, Citterio L, Petit T, Carpini SD, Zhang Z, Jacobs L, Jin Y, Barlassina C, Manunta P, Kuznetsova T, Verhamme P, Struijker-Boudier HA, Cusi D, Vermeer C, Staessen JA. Liu YP, et al. Among authors: thijs l. Hypertension. 2015 Feb;65(2):463-70. doi: 10.1161/HYPERTENSIONAHA.114.04494. Epub 2014 Nov 24. Hypertension. 2015. PMID: 25421980
Withdrawal from treatment in the Syst-Eur Trial.
Bulpitt CJ, Beckett NS, Fletcher AE, Thijs L, Staessen JA, Dumitrascu DL, Forette F, Leonetti G, Nachev C, Tuomilehto J, Fagard RH; Syst-Eur investigators. Bulpitt CJ, et al. Among authors: thijs l. J Hypertens. 2002 Feb;20(2):339-46. doi: 10.1097/00004872-200202000-00026. J Hypertens. 2002. PMID: 11821721 Free article. Clinical Trial.
Subgroup analysis of the NORDIL trial.
Thijs L, Staessen JA, Wang J, Fagard R. Thijs L, et al. J Hypertens. 2002 Jun;20(6):1085-7. doi: 10.1097/00004872-200206000-00018. J Hypertens. 2002. PMID: 12023676 Free article. No abstract available.
Prognostic significance of renal function in elderly patients with isolated systolic hypertension: results from the Syst-Eur trial.
De Leeuw PW, Thijs L, Birkenhäger WH, Voyaki SM, Efstratopoulos AD, Fagard RH, Leonetti G, Nachev C, Petrie JC, Rodicio JL, Rosenfeld JJ, Sarti C, Staessen JA; Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. De Leeuw PW, et al. Among authors: thijs l. J Am Soc Nephrol. 2002 Sep;13(9):2213-22. doi: 10.1097/01.asn.0000027871.86296.92. J Am Soc Nephrol. 2002. PMID: 12191965 Clinical Trial.
Quality of life on randomized treatment for isolated systolic hypertension: results from the Syst-Eur Trial.
Fletcher AE, Bulpitt CJ, Thijs L, Tuomilehto J, Antikainen R, Bossini A, Browne J, Duggan J, Kawecka-Jaszcz K, Kivinen P, Sarti C, Terzoli L, Staessen JA; Syst-Eur Trial Investigators. Fletcher AE, et al. Among authors: thijs l. J Hypertens. 2002 Oct;20(10):2069-79. doi: 10.1097/00004872-200210000-00028. J Hypertens. 2002. PMID: 12359987 Clinical Trial.
Cardiovascular risk in white-coat and sustained hypertensive patients.
Celis H, Staessen JA, Thijs L, Buntinx F, De Buyzere M, Den Hond E, Fagard RH, O'Brien ET; Ambulatory Blood Pressure and Treatment of Hypertension Trial Investigators. Celis H, et al. Among authors: thijs l. Blood Press. 2002;11(6):352-6. doi: 10.1080/080370502321095311. Blood Press. 2002. PMID: 12523678 Clinical Trial.
What can be expected from optimal blood pressure control?
Staessen JA, Wang JG, Thijs L. Staessen JA, et al. Among authors: thijs l. J Hypertens Suppl. 2003 May;21(2):S3-9. doi: 10.1097/00004872-200305002-00002. J Hypertens Suppl. 2003. PMID: 12929901
780 results